Synthesis and Evaluation of Metabotropic Glutamate Receptor Subtype 5 Antagonists Based on Fenobam

被引：7

作者：

Gichinga, Moses G. ^{[1
]}

Olson, Jeremy P. ^{[1
]}

Butala, Elizabeth ^{[1
]}

Navarro, Hernan A. ^{[1
]}

Gilmour, Brian P. ^{[1
]}

Mascarella, S. Wayne ^{[1
]}

Carroll, F. Ivy ^{[1
]}

机构：

[1] Res Triangle Inst, Ctr Organ & Med Chem, Res Triangle Pk, NC 27709 USA

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2011年 / 2卷 / 12期

关键词：

Fenobam; metabotropic glutamate receptors; drug addiction; mGluR5; antagonist; POTENT; ANALOGS; DERIVATIVES; PLACEBO; COCAINE; MICE;

D O I：

10.1021/ml200162f

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

In an effort to discover potent and selective metabotropic glutamate receptor subtype 5 (mGluR5) antagonists, 15 tetrahydropyrimidinone analogues of 1-(3-chlorophenyl)-3-(1-methyl-4-oxo-4,5-dihydro-1H-imidazol-2-yl)-urea (fenobam) were synthesized. These compounds were evaluated for antagonism of glutamate-mediated mobilization of internal calcium in an mGluR5 in vitro efficacy assay. The IC50 value for 1-(3-chlorophenyl)-3-(1-methyl-4-oxo-1,4,5,6-tetrahydropyridine)urea (4g) was essentially identical to that of fenobam.

引用

页码：882 / 884

页数：3

共 20 条

[1] Synthesis and receptor assay of aromatic-ethynyl-aromatic derivatives with potent mGluR5 antagonist activity [J].

Alagille, D ;

Baldwin, RM ;

Roth, BL ;

Wroblewski, JT ;

Grajkowska, E ;

Tamagnan, GD .

BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (01) :197-209

[2] Therapeutic implications of the mGluR theory of fragile X mental retardation [J].

Bear, MF .

GENES BRAIN AND BEHAVIOR, 2005, 4 (06) :393-398

[3] A pilot open label, single dose trial of fenobam in adults with fragile X syndrome [J].

Berry-Kravis, E. ;

Hessl, D. ;

Coffey, S. ;

Hervey, C. ;

Schneider, A. ;

Yuhas, J. ;

Hutchison, J. ;

Snape, M. ;

Tranfaglia, M. ;

Nguyen, D. V. ;

Hagerman, R. .

JOURNAL OF MEDICAL GENETICS, 2009, 46 (04) :266-271

[4] Synthesis and pharmacological evaluation of phenylethynyl[1,2,4]methyltriazines as analogues of 3-methyl-6-(phenylethynyl)pyridine [J].

Carroll, F. Ivy ;

Kotturi, Sharadsrikar V. ;

Navarro, Hernan A. ;

Mascarella, S. Wayne ;

Gilmour, Brian P. ;

Smith, Forrest L. ;

Gabra, Bichoy H. ;

Dewey, William L. .

JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (14) :3388-3391

[5] Rational design, synthesis, and structure-activity relationship of benzoxazolones: New potent mglu5 receptor antagonists based on the fenobam structure [J].

Ceccarelli, Siniona M. ;

Jaeschke, Georg ;

Buettelmann, Bernd ;

Huwyler, Joerg ;

Kolczewski, Sabine ;

Peters, Jens-Uwe ;

Prinssen, Eric ;

Porter, Richard ;

Spooren, Will ;

Vieira, Eric .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (05) :1302-1306

[6] Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice [J].

Chiamulera, C ;

Epping-Jordan, MP ;

Zocchi, A ;

Marcon, C ;

Cottiny, C ;

Tacconi, S ;

Corsi, M ;

Orzi, F ;

Conquet, F .

NATURE NEUROSCIENCE, 2001, 4 (09) :873-874

[7] Cyclohexenyl- and dehydropiperidinyl-alkynyl pyridines as potent metabotropic glutamate subtype 5 (mGlu5) receptor antagonists [J].

Chua, PC ;

Nagasawa, JY ;

Bleicher, LS ;

Munoz, B ;

Schweiger, EJ ;

Tehrani, L ;

Anderson, JJ ;

Cramer, M ;

Chung, J ;

Green, MD ;

King, CD ;

Reyes-Manalo, G ;

Cosford, NDP .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (20) :4589-4593

[8] Up-regulation of metabotropic glutamate receptor subtypes 3 and 5 in spinal cord in a clinical model of persistent inflammation and hyperalgesia [J].

Dolan, S ;

Kelly, JG ;

Monteiro, AM ;

Nolan, AM .

PAIN, 2003, 106 (03) :501-512

[9]

FRIEDMANN CTH, 1980, CURR THER RES CLIN E, V27, P144

[10] Synthesis and structure-activity relationships of 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine analogues as potent, noncompetitive metabotropic glutamate receptor subtype 5 antagonists; Search for cocaine medications [J].

Iso, Y ;

Grajkowska, E ;

Wroblewski, JT ;

Davis, J ;

Goeders, NE ;

Johnson, KM ;

Sanker, S ;

Roth, BL ;

Tueckmantel, W ;

Kozikowski, AP .

JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (03) :1080-1100

← 1 2 →